Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Thursday Feb 06, 2025
Thursday Feb 06, 2025
touchCONGRESS for ONCOLOGY
Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of the data for clinical practice.
The experts
- Prof. Katja Weisel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Dr Nisha Joseph, Emory University School of Medicine, Atlanta, GA, USA
- Prof. Roman Hájek, University Hospital Ostrava, Ostrava, Czech Republic
This touchPODCAST is for HCPs outside of the USA and UK.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/bcma-directed-therapies-in-multiple-myeloma-ash2024/
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.